Molecular docking, dynamics simulations and 3D-QSAR modeling of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR agonists

被引:19
作者
Sherin, D. R. [1 ]
Geethu, C. K. [1 ]
Prabhakaran, Jaya [2 ,3 ]
Mann, J. John [2 ,3 ]
Kumar, J. S. Dileep [2 ,3 ]
Manojkumar, T. K. [1 ]
机构
[1] Indian Inst Informat Technol & Management Kerala, Ctr Data Engn & Computat Modeling, Kazhakkoottam, India
[2] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Mol Imaging & Neuropathol Div, New York, NY 10027 USA
[3] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10027 USA
关键词
5-HT1AR agonist; Arylpiperazine; Homology model; Molecular docking; Molecular dynamics; 3D-QSAR; SEROTONIN RECEPTORS; PET TRACERS; BINDING; IDENTIFICATION; POTENT; PHASE; GLIDE;
D O I
10.1016/j.compbiolchem.2018.11.015
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Serotonin receptor, 5-HT1AR, agonists and partial agonists have established drug candidates for psychiatric and neurologic disorders. Recently, we reported the synthesis and evaluation of arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine as 5-HT1AR ligands. Herein, we generated a homology model of the receptor and docked the ligands against it, predicted the stability of the receptor model and complexes by molecular dynamics and generated a 3D-QSAR model for the arylpiperazine derivatives of 3,5-dioxo-(2H,4H)-1,2,4-triazine. The model suggests the hydrophobic part that arises from the aromatic region and the electron withdrawing parts play a vital role in the agonist activity of the lead molecules.
引用
收藏
页码:108 / 115
页数:8
相关论文
共 37 条
[1]  
[Anonymous], 2017, SMALL MOL DRUG DISC
[2]   Derivatives as 5HT1A receptor ligands -: Past and present [J].
Caliendo, G ;
Santagada, V ;
Perissutti, E ;
Fiorino, F .
CURRENT MEDICINAL CHEMISTRY, 2005, 12 (15) :1721-1753
[3]   Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research [J].
Celada, Pau ;
Bortolozzi, Analia ;
Artigas, Francesc .
CNS DRUGS, 2013, 27 (09) :703-716
[4]   Synthesis and pharmacological evaluation of new 5-(cyclo)alkyl-5-phenyl- and 5-spiroimidazolidine-2,4-dione derivatives. Novel 5-HT1A receptor agonist with potential antidepressant and anxiolytic activity [J].
Czopek, Anna ;
Byrtus, Hanna ;
Kolaczkowski, Marcin ;
Pawlowski, Maciej ;
Dybala, Malgorzata ;
Nowak, Gabriel ;
Tatarczynska, Ewa ;
Wesolowska, Anna ;
Chojnacka-Wojcik, Ewa .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (04) :1295-1303
[5]   Vilazodone: A 5-HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders [J].
Dawson, Lee A. ;
Watson, Jeannette M. .
CNS NEUROSCIENCE & THERAPEUTICS, 2009, 15 (02) :107-117
[6]   PHASE: A novel approach to pharmacophore modeling and 3D database searching [J].
Dixon, Steven L. ;
Smondyrev, Alexander M. ;
Rao, Shashidhar N. .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (05) :370-372
[7]   PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results [J].
Dixon, Steven L. ;
Smondyrev, Alexander M. ;
Knoll, Eric H. ;
Rao, Shashidhar N. ;
Shaw, David E. ;
Friesner, Richard A. .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2006, 20 (10-11) :647-671
[8]   Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists [J].
Dounay, Amy B. ;
Barta, Nancy S. ;
Bikker, Jack A. ;
Borosky, Susan A. ;
Campbell, Brian M. ;
Crawford, Terry ;
Denny, Lynne ;
Evans, Lori M. ;
Gray, David L. ;
Lee, Pil ;
Lenoir, Edward A. ;
Xu, Wenjian .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (04) :1159-1163
[9]  
Erik L, 2011, MED CHEM LET, V2, P834
[10]   5-HT1A Receptor: An Old Target as a New Attractive Tool in Drug Discovery from Central Nervous System to Cancer [J].
Fiorino, Ferdinando ;
Severino, Beatrice ;
Magli, Elisa ;
Ciano, Antonio ;
Caliendo, Giuseppe ;
Santagada, Vincenzo ;
Frecentese, Francesco ;
Perissutti, Elisa .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) :4407-4426